Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
February 25th, 2026
California Disney Fine Pushes Companies to Fully Honor Opt-Outs
Bloomberg Law quoted Daniel M. Goldberg in their recent article about how California fined Disney $2.75 million for allegedly failing to fully honor consumers’ opt-out requests under the California Consumer Privacy Act, signaling increased scrutiny of how companies implement privacy rights across devices, services, and systems. The enforcement action underscores regulators’ growing expectation that opt-out mechanisms must work seamlessly and consistently, with technical compliance now under closer investigation. Daniel stated,"What I think is so big about this is that there's an expectation, an increasing expectation that this opt out really has to work." View the full article on the opt-out requests under the California Consumer Privacy Act. Reproduced with permission. Copyright February 13, 2026 by Bloomberg Industry Group, Inc. (800-372-1033) http://www.bloombergindustry.com.
Other Quoted
Climate Diaries Cannes Lions 2026
Jeffrey A. Greenbaum is featured in the 51toCarbonZero article, Climate Diaries Cannes Lions 2026, which features eleven interviews with senior leaders from across the media and advertising industry conducted at the Cannes Lions International Festival of Creativity. Read more.
August 5 2026
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
